Announced Tue, 30 Jun · 16:43 IST
Board okays name change, pharma expansion, 2 directors and office shift
Management Changes View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.3%1-day move
₹0.75
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+1.3+4.0+2.7+1.3+2.7+5.3+2.7———
Up moveDown movePending
AI summary
Board approved several items: proposed name change from Sattva Sukun Lifecare to one of Tavexia, Trumaxa, Trustarex or Tradamex Lifecare; expanded MOA objects to add chemicals, APIs, pharma formulations, nutraceuticals, biotech and CRO/CDMO services; regularized Sachin Manseta as Independent Director and Chirag Dedhia as Non-Executive Director; and shifted registered office within Kandivali West Mumbai from July 1, 2026. EGM called for shareholder approval.
Likely market impact
Suggests a strategic pivot into pharma, chemicals and biotech under a new brand. Pending shareholder approval at the upcoming EGM.